Age-specific seroprevalence of human herpesvirus 8 in Mediterranean regions

Clinical Microbiology and Infection

Volumn 9, Issue 4, 2003, Pages 274-279

  Cattani, P ^a   Cerimele, F ^a   Porta, D ^e   Graffeo, R ^a   Ranno, S ^a   Marchetti, S ^a   Ricci, R ^a   Capodicasa, N ^b   Fuga, L ^b   Amico, R ^b   Cherchi, G ^c   Gazzilli, M ^c   Zanetti, S ^d   Fadda, G ^a  

^a CATHOLIC UNIVERSITY   (Italy)

^b Poliambulatorio Padre L Monti   (Albania)

^c SS Annunziata Hospital   (Italy)

^d UNIVERSITY OF SASSARI   (Italy)

^e NONE

Author keywords

Anti HHV8 antibodies; Human herpesvirus 8; Kaposi's sarcoma associated herpesvirus; Seroprevalence

Indexed keywords

ADOLESCENT; ADULT; AFRICA; AGE; AGED; ALBANIA; ARTICLE; CHILD; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIOLOGICAL DATA; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNOFLUORESCENCE TEST; INFANT; ITALY; MAJOR CLINICAL STUDY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; SEROPREVALENCE; SEXUAL INTERCOURSE; SOUTHERN EUROPE; STATISTICAL SIGNIFICANCE; VIRUS INFECTION; VIRUS TRANSMISSION;

HERPESVIRIDAE; HUMAN HERPESVIRUS 8;

EID: 0037734073     PISSN: 1198743X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1469-0691.2003.00490.x     Document Type: Article

References (32)

1. Chang Y, Cesarman E, Pessin MS et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-9.
2. Schalling M, Ekman M, Kaaya EE et al. A role for a new herpes virus (KSHV) in different forms of Kaposi's sarcoma. Nat Med 1995; 1: 707-8.
3. Luppi M, Barozzi P, Maiorana A et al. Frequency and distribution of herpesvirus-like DNA sequences (KSHV) in different stages of classic Kaposi's sarcoma and in normal tissues from an Italian population. Int J Cancer 1996; 66: 427-31.
4. Corbellino M, Poirel L, Bestetti G et al. Restricted tissue distribution of extralesional Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS patients with Kaposi's sarcoma. AIDS Res Hum Retroviruses 1996; 12: 651-7.
5. Chang Y, Moore PS. Kaposi's Sarcoma (KS) - associated herpesvirus and its role in KS. Infect Agents Dis 1996; 5: 215-22.
6. Buonaguro FM, Tornesello ML, Beth-Giraldo E et al. Herpesvirus-like DNA sequences detected in endemic, classic, iatrogenic and epidemic Kaposi's sarcoma (KS) biopsies. Int J Cancer 1996; 65: 25-8.
7. Brambilla L, Boneschi V, Berti E et al. HHV8 cell-associated viraemia and clinical presentation of Mediterranean Kaposi's sarcoma. Lancet 1996; 347: 1338.
8. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma patients with and without HIV infection. N Engl J Med 1995; 332: 1181-5.
9. Bigoni B, de Dolcetti R, de Lellis L et al. Human herpesvirus 8 is present in the lymphoid system of healthy persons and can reactivate in the course of AIDS. J Infect Dis 1996; 173: 542-9.
10. Cattani P, Capuano M, Lesnoni La Parola I et al. Human herpesvirus 8 in Italian HIV-seronegative patients with Kaposi sarcoma. Arch Dermatol 1998; 134: 695-9.
11. Chang Y, Ziegler J, Wabinga H et al. Kaposi's sarcoma-associated herpesvirus and Kaposi's sarcoma in Africa. Uganda Kaposi's Sarcoma Study Group. Arch Intern Med 1996; 156: 202-4.
12. Mayama S, Cuevas LE, Sheldon J et al. Prevalence and transmission of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in Ugandan children and adolescents. Int J Cancer 1998; 77: 817-20.
13. Rezza G, Lennette ET, Giuliani M et al. Prevalence and determinants of anti-lytic and anti-latent antibodies to human herpesvirus-8 among Italian individuals at risk of sexually and parenterally transmitted infections. Int J Cancer 1998; 77: 361-5.
14. Rezza G, Tchangmena OB, Andreoni M et al. Prevalence and risk factors for human herpesvirus 8 infection in northern Cameroon. Sex Transm Dis 2000; 27: 159-64.
15. Cattani P, Capuano M, Cerimele F et al. Human herpesvirus 8 seroprevalence and evaluation of nonsexual transmission routes by detection of DNA in clinical specimens from human immunodeficiency virus-seronegative patients from central and southern Italy, with and without Kaposi's sarcoma. J Clin Microbiol 1999; 37: 1150-3.
16. Gao SJ, Kingsley L, Li M et al. KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med 1996; 2: 925-8.
17. Lennette ET, Blackbourn DJ, Levy JA. Antibodies to human herpesvirus type 8 in the general population and in Kaposi's sarcoma patients. Lancet 1996; 348: 858-61.
18. Olsen SJ, Chang Y, Moore PS et al. Increasing Kaposi's sarcoma-associated herpesvirus seroprevalence with age in a highly Kaposi's sarcoma endemic region, Zambia in 1985. Aids 1998; 12: 1921-5.
19. Ariyoshi K, Schim van der Loeff M, Cook P et al. Kaposi's sarcoma in the Gambia, West Africa is less frequent in human immunodeficiency virus type 2 than in human immunodeficiency virus type 1 infection despite a high prevalence of human herpesvirus 8. J Hum Virol 1998; 1: 193-9.
20. Blackbourn DJ, Lennette ET, Ambroziak J et al. Human herpesvirus 8 detection in nasal secretions and saliva. J Infect Dis 1998; 177: 213-6.
21. Boldogh I, Szaniszlo P, Bresnahan WA et al. Kaposi's sarcoma herpesvirus-like DNA sequences in the saliva of individuals infected with human immunodeficiency virus. Clin Infect Dis 1996; 23: 406-7.
22. Koelle DM, Huang ML, Chandran B et al. Frequent detection of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) DNA in saliva of human immunodeficiency virus-infected men: clinical and immunologic correlates. J Infect Dis 1997; 176: 94-102.
23. Vieira J, Huang ML, Koelle DM et al. Transmissible Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in saliva of men with a history of Kaposi's sarcoma. J Virol 1997; 71: 7083-7.
24. Miller G, Rigsby MO, Heston L et al. Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med 1996; 334: 1292-7.
25. Renne R, Zhong W, Herndier B et al. Lytic growth of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in culture. Nat Med 1996; 2: 342-6.
26. Angeloni A, Heston L, Uccini S et al. High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 1998; 8: 1715-8.
27. Kedes DH, Operskalski E, Busch M et al. The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma- associated herpesvirus): distribution of infection in KS risk groups and evidence for sexual transmission. Nat Med 1996; 2: 918-24.
28. Whitby D, Luppi M, Barozzi P et al. Human herpesvirus 8 seroprevalence in blood donors and lymphoma patients from different regions of Italy. J Natl Cancer Inst 1998; 90: 395-7.
29. Potouridou I, Katsambas A, Pantazi V et al. Classic Kaposi's sarcoma in two young heterosexual men. J Eur Acad Dermatol Venereol 1998; 10: 48-52.
30. Andreoni M, El-Sawaf G, Rezza G et al. High seroprevalence of antibodies to human herpesvirus-8 in Egyptian children: evidence of nonsexual transmission. J Natl Cancer Inst 1999; 91: 465-9.
31. Franceschi S, Geddes M. Epidemiology of classic Kaposi's sarcoma, with special reference to mediterranean population. Tumori 1995; 81: 308-14.
32. Cottoni F, De Marco R, Montesu MA. Classical Kaposi's sarcoma in north-east Sardinia: an overview from 1977 to 1991. Br J Cancer 1996; 73: 1132-3.